CSTL vs XGN: stock comparison and AI forecast
Castle Biosciences Inc (CSTL) and Exagen Inc. (XGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CSTL Castle Biosciences Inc
- Price
- $32.52 +69.0% · 6M
- Market Cap
- $993M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
XGN Exagen Inc.
- Price
- $7.60 +158.5% · 6M
- Market Cap
- $184M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CSTL is 5.4 times larger than XGN by market capitalization ($993M against $184M).
- Over the last six months XGN returned +158.5% and CSTL +69.0%.
- CSTL turns -6.1% of its revenue into net income, against -26.6% for XGN.
- XGN carries 3.25 times debt per unit of equity, against 0.21 times for CSTL.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CSTL | XGN |
|---|---|---|
| Market Cap | $993M | $184M |
| P/B Ratio | 2.08x | 15.07x |
| EPS | $-0.94 | $-0.85 |
| Book Value/Share | $15.66 | $0.50 |
| Revenue/Share | $12.34 | $2.94 |
| FCF/Share | $0.13 | $-0.31 |
Profitability & Margins
| Metric | CSTL | XGN |
|---|---|---|
| ROE | -4.8% | -154.9% |
| ROA | -4.0% | -36.4% |
| ROIC | -5.5% | -34.3% |
| Gross Margin | 77.1% | 58.6% |
| Operating Margin | -7.4% | -18.6% |
| Net Margin | -6.1% | -26.6% |
| EBT Margin | -7.4% | -18.6% |
| Tax Rate | -1.4% | -0.4% |
Financial Health
| Metric | CSTL | XGN |
|---|---|---|
| Current Ratio | 5.28x | 3.18x |
| Quick Ratio | 5.12x | – |
| D/E Ratio | 0.21x | 3.25x |
| Financial Leverage | 1.21x | 4.25x |
| Interest Coverage | -14.4x | -2.0x |
| Working Capital | $289M | $29M |
Cash Flow
| Metric | CSTL | XGN |
|---|---|---|
| Operating Cash Flow | $40M | -$6M |
| Free Cash Flow | $4M | -$8M |
| Capital Spending | -$36M | -$1M |
| OCF Growth YoY | -35.7% | – |
| FCF Growth YoY | -84.4% | – |
| FCF/Sales | 1.1% | -10.7% |
| CapEx/Sales | 9.5% | 1.5% |
Operational Efficiency
| Metric | CSTL | XGN |
|---|---|---|
| Asset Turnover | 0.65x | 1.37x |
| Receivables Turnover | 7.2x | 5.7x |
| Inventory Turnover | 8.3x | – |
| Fixed Assets Turnover | 3.4x | 10.8x |
| Days Sales Outstanding | 50 days | 64 days |
| Days Inventory | 44 days | – |
| Payables Period | 56 days | 55 days |
| Cash Conversion Cycle | 38 days | – |
Income Statement
| Metric | CSTL | XGN |
|---|---|---|
| Total Revenue | $377M | $71M |
| Operating Income | -$28M | -$13M |
| Net Income | -$23M | -$19M |
| R&D Expense | $58M | $6M |
| SG&A Expense | $252M | $48M |
| Cost of Goods Sold | $86M | $29M |
Dividend & Shareholder Information
| Metric | CSTL | XGN |
|---|---|---|
| Shares Outstanding | 31M | 24M |
| EPS Growth | -280.8% | – |
CSTL vs XGN: stock comparison and AI forecast
Which is bigger, CSTL or XGN?
CSTL is 5.4 times larger than XGN by market capitalization ($993M against $184M).
Which stock performed better over the last six months, CSTL or XGN?
Over the last six months XGN returned +158.5% and CSTL +69.0%.
Which one does Intratio's AI model rank higher, CSTL or XGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.